564 | Nature | Vol 582 | 25 June 2020
Article
First cases
identied in
Wuhan
Early Dec14 synSARS-CoV-2
DNA segments
ordered
14 JanFirst
genome
sequence
released
10 JanA new
coronavirus
conrmed
by CDC
China
7 JanWHO
notication:
pneumonia
caused by an
unknown virus
31 DecFive more genome
sequences
released
11 Jan12 out of 14
synSARS-CoV- 2
DNA segments
received
4 Feb
SARS-CoV- 2
viral RNA received
5 FebFull-length
cDNA clones
obtained
8 Feb
rSARS-CoV- 2
rescued
12 FebFirst
SARS-CoV-2
isolate
outside China
(Australia)
28 JanDNA synthesis SARS-CoV- 2
reconstructionThe name
SARS-CoV- 2
is announced
(ICTV)
11 FebA pandemic
is declared
by WHO
11 MarDecember January February MarchFig. 2 | Timeline of the reconstruction and recovery of rSARS-CoV-2 in
relation to key events of the COVID-19 pandemic. Illustration of the rapidity
of rSARS-CoV-2 reconstruction along with the timeline of key events of the
COVID-19 pandemic. CDC, Center for Disease Control and Prevention; ICTV,
International Committee on Taxonomy of Viruses; WHO, World Health
Organization.ab
Clone 1.1 Clone 2.2 Clone 3.1 Mock10 –110 –210 –3c012345678Time (h after infection)log(TCID 10ml 50–1)Clone 1.1
Clone 2.2
Clone 3.1
SARS-CoV-2 isolate
6 12 18 24 30 40NS
NS
NSNS
NS
NS*
*NS ** *
NS NS NS
NS NS NS NS40012345678Time (h after infection)log(TCID 10ml 50–1)6 12 18 24 30Clone 4.1
Clone 5.2
Clone 6.2
SynSARS-CoV-2-GFP
SARS-CoV-2 isolateNSNS * ****SARS-CoV-2DNA
fragmentsDNA
fragmentsSARS-CoV-2-GFP010Genome sequence (kb)
20 30
1a
1bS3EM6/7b7a/8N1
23
45
67
89
1011
123E
M6
7a 7a7b
GFP 8N13
1415A
CB
D
AaAb
BsynSARS-CoV-2
fragmentsClone 4.1 Clone 5.2 Clone 6.2 MockelectrRNAoporation rSARS-CoV-2 rSARS-CoV-2-GFPPlaque assayFluorescence microscopyrSARS-CoV- 2rSARS-CoV-2-GFPNSNSNSNS * ****
NSNS * ****
* ****Fig. 3 | Reconstruction, rescue and characterization of rSARS-CoV-2,
rSARS-CoV-2-GFP and synSARS-CoV-2-GFP. a, Schematic representation of
the SARS-CoV-2 genome organization and DNA fragments used to clone
rSARS-CoV-2, rSARS-CoV-2-GFP and synSARS-CoV-2-GFP. Inserts show
synthetic subfragments comprising fragments 5 (A–D) and 7 (Aa, Ab, B), and the
fragments used to insert the GFP gene (fragments 13–15). b, Left, schematic of
the experiment. Middle, rescue of rSARS-CoV-2 from yeast clones 1.1, 2.2 and
3.1. Supernatants (10−1, 10−2 and 10−3 ml) of cells infected with the indicated
clones or mock-infected cells were transferred to Vero E6 cells to detect
plaques (rSARS-CoV-2). Right, rescue of rSARS-CoV-2-GFP from yeast clones
4.1, 5.2 and 6.2. Supernatants (1 ml) from individual rescue experiments were
transferred to Vero E6 cells to detect green f luorescence (rSARS-C oV-2- G F P).
Mock, uninfected cells. Scale bars, 100 μm. c, Replication kinetics of
rSARS-CoV-2 clones 1.1, 2.2, 3.1 (left) and rSARS-CoV-2-GFP clones 4.1, 5.2, 6.2
and synSARS-CoV-2-GFP (right) compared with the SARS-CoV-2 isolate. Vero E6
cells were infected (MOI = 0.01), and supernatants were collected at the
indicated time points after infection and titrated (50% tissue culture infectious
dose (TCID 50 ) assay). Data represent the mean ± s.d. of three independent
biological replicates. Statistical significance was determined for each clone
against the SARS-CoV-2 isolate by two-sided unpaired Student’s t-test without
adjustments for multiple comparisons. P values (from left to right): left, top,
NS, P = 0.0851; NS, P = 0.1775; *P = 0.0107; NS, P = 0.0648; **P = 0.0013;
*P = 0.0373; middle, NS, P = 0.0851; NS, P = 0.1713; *P = 0.0133; NS, P = 0.0535; NS,
P = 0.0909; NS, P = 0.0632; bottom, NS, P = 0.1119; NS, P = 0.1641; NS, P = 0.0994;
NS, P = 0.4921; NS, P = 0.3336; NS, P = 0.0790; right, top, NS, P = 0.0858; NS,
P = 0.1429; *P = 0.0104; *P = 0.0466; **P = 0.0011; *P = 0.0287; second, NS,
P = 0.0872; NS, P = 1 360; *P = 0.0102; *P = 0.0461; **P = 0.0011; *P = 0.0282; third,
NS, P = 0.4810; NS, P = 0.1758; *P = 0.0106; *P = 0.0478; **P = 0.0011; *P = 0.0287;
bottom, NS, P = 0.3739; NS, P = 0.6817; *P = 0.0106; *P = 0.0473; **P = 0.0011
*P = 0.02 8 5.